en
Scientific article
English

The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer

Published inUrologic oncology, vol. 34, no. 12, p. 533.e1-533.e10
Publication date2016
Abstract

The aim of this study was to evaluate the overexpression of human epidermal growth factor receptor 2 (HER2) in patients with bladder cancer (BCa) and to assess its association with oncological outcomes.

Keywords
  • Bladder cancer
  • HER2
  • Prognosis
  • Recurrence
  • Survival
  • Target therapy
Citation (ISO format)
SORIA, Francesco et al. The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer. In: Urologic oncology, 2016, vol. 34, n° 12, p. 533.e1–533.e10. doi: 10.1016/j.urolonc.2016.07.006
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1078-1439
336views
0downloads

Technical informations

Creation03/02/2017 4:05:00 PM
First validation03/02/2017 4:05:00 PM
Update time03/15/2023 1:36:49 AM
Status update03/15/2023 1:36:49 AM
Last indexation01/16/2024 11:48:41 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack